Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hematologic malignancies;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Neoplasms

Drugs mentioned

• Busulfex (busulfan)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-17